Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness

Cancer Letters

Volumn 324, Issue 1, 2012, Pages 31-41

  Comito, Giuseppina ^a   Giannoni, Elisa ^a   Gennaro, Paola Di ^a   Segura, Coral Pons ^a   Gerlini, Gianni ^a   Chiarugi, Paola ^a  

^a ISTITUTO TOSCANO TUMORI   (Italy)

Author keywords

Hypoxia; IL 6; Melanoma; Stromal fibroblast; VEGF

Indexed keywords

INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN A;

ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL INVASION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MACROPHAGE; MELANOMA CELL; MYOFIBROBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN FIBROBLAST; TUMOR MICROENVIRONMENT;

CELL HYPOXIA; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOTAXIS; CYTOKINES; FIBROBLASTS; HUMANS; INTERLEUKIN-6; MACROPHAGES; MELANOMA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SKIN; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864039745     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.04.025     Document Type: Article

References (52)

1. Braeuer R.R., Zigler M., Villares G.J., Dobroff A.S., Bar-Eli M. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Semin. Cancer Biol. 2011, 21:83-88.
2. Ch'ng S., Tan S.T. Genetics, cellular biology and tumor microenvironment of melanoma. Front Biosci. 2009, 14:918-928.
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
4. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
5. Lynch C.C., Matrisian L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002, 70:561-573.
6. Midwood K.S., Williams L.V., Schwarzbauer J.E. Tissue repair and the dynamics of the extracellular matrix. Int. J. Biochem. Cell Biol. 2004, 36:1031-1037.
7. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 1999, 59:5002-5011.
8. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
9. Orimo A., Weinberg R.A. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006, 5:1597-1601.
10. Hayward S.W., Wang Y., Cao M., Hom Y.K., Zhang B., Grossfeld G.D., Sudilovsky D., Cunha G.R. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 2001, 61:8135-8142.
11. Giannoni E., Bianchini F., Masieri L., Serni S., Torre E., Calorini L., Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 2010, 70:6945-6956.
12. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid. Redox Signal. 2011.
13. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147.
14. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
15. Crawford Y., Kasman I., Yu L., Zhong C., Wu X., Modrusan Z., Kaminker J., Ferrara N. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009, 15:21-34.
16. Leiter U., Meier F., Schittek B., Garbe C. The natural course of cutaneous melanoma. J. Surg. Oncol. 2004, 86:172-178.
17. Villanueva J., Herlyn M. Melanoma and the tumor microenvironment. Curr. Oncol. Rep. 2008, 10:439-446.
18. Li G., Satyamoorthy K., Meier F., Berking C., Bogenrieder T., Herlyn M. Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 2003, 22:3162-3171.
19. Lazar-Molnar E., Hegyesi H., Toth S., Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000, 12:547-554.
20. Li L., Dragulev B., Zigrino P., Mauch C., Fox J.W. The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo. Int. J. Cancer 2009, 125:1796-1804.
21. Satyamoorthy K., Li G., Vaidya B., Patel D., Herlyn M. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. Cancer Res. 2001, 61:7318-7324.
22. Ma D.R., Yang E.N., Lee S.T. A review: the location, molecular characterisation and multipotency of hair follicle epidermal stem cells. Ann. Acad. Med. Singapore 2004, 33:784-788.
23. Chiarugi P., Pani G., Giannoni E., Taddei L., Colavitti R., Raugei G., Symons M., Borrello S., Galeotti T., Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 2003, 161:933-944.
24. van Kempen L.C., van Muijen G.N., Ruiter D.J. Melanoma progression in a changing environment. Eur. J. Cell Biol. 2007, 86:65-67.
25. Cirri P., Chiarugi P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev. 2011.
26. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
27. Giannoni E., Bianchini F., Calorini L., Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid. Redox Signal. 2011, 14:2361-2371.
28. Blick T., Hugo H., Widodo E., Waltham M., Pinto C., Mani S.A., Weinberg R.A., Neve R.M., Lenburg M.E., Thompson E.W. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J. Mammary. Gland. Biol. Neoplasia. 2010, 15:235-252.
29. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
30. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
31. Desmouliere A., Guyot C., Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int. J. Dev. Biol. 2004, 48:509-517.
32. Pietras K., Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 2010, 316:1324-1331.
33. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J. Pathol. 2003, 200:500-503.
34. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 2009, 119:1417-1419.
35. Lohr M., Schmidt C., Ringel J., Kluth M., Muller P., Nizze H., Jesnowski R. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 2001, 61:550-555.
36. Javelaud D., Alexaki V.I., Dennler S., Mohammad K.S., Guise T.A., Mauviel A. TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res. 2011, 71:5606-5610.
37. Mantovani A., Germano G., Marchesi F., Locatelli M., Biswas S.K. Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur. J. Immunol. 2011, 41:2522-2525.
38. Payne S.J., Jones L. Influence of the tumor microenvironment on angiogenesis. Future. Oncol. 2011, 7:395-408.
39. Qian B.Z., Pollard J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
40. Lee J.T., Herlyn M. Microenvironmental influences in melanoma progression. J. Cell. Biochem. 2007, 101:862-872.
41. Giaccia A.J., Schipani E. Role of carcinoma-associated fibroblasts and hypoxia in tumor progression. Curr. Top. Microbiol. Immunol. 2010, 345:31-45.
42. Melillo G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev. 2007, 26:341-352.
43. Stewart F.A., Denekamp J., Randhawa V.S. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia. Br. J. Cancer 1982, 45:869-877.
44. Comito G., Calvani M., Giannoni E., Bianchini F., Calorini L., Torre E., Migliore C., Giordano S., Chiarugi P. HIF-1alpha stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic. Biol. Med. 2011, 51:893-904.
45. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008, 15:660-666.
46. Lu H., Dalgard C.L., Mohyeldin A., McFate T., Tait A.S., Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 2005, 280:41928-41939.
47. Semenza G.L. Oxygen homeostasis. Wiley. Interdiscipl. Rev. Syst. Biol. Med. 2010, 2:336-361.
48. Gao P., Zhang H., Dinavahi R., Li F., Xiang Y., Raman V., Bhujwalla Z.M., Felsher D.W., Cheng L., Pevsner J., Lee L.A., Semenza G.L., Dang C.V. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell 2007, 12:230-238.
49. Cat B., Stuhlmann D., Steinbrenner H., Alili L., Holtkotter O., Sies H., Brenneisen P. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J. Cell Sci. 2006, 119:2727-2738.
50. Toullec A., Gerald D., Despouy G., Bourachot B., Cardon M., Lefort S., Richardson M., Rigaill G., Parrini M.C., Lucchesi C., Bellanger D., Stern M.H., Dubois T., Sastre-Garau X., Delattre O., Vincent-Salomon A., Mechta-Grigoriou F. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol. Med. 2010, 2:211-230.
51. Youn S.W., Lee S.W., Lee J., Jeong H.K., Suh J.W., Yoon C.H., Kang H.J., Kim H.Z., Koh G.Y., Oh B.H., Park Y.B., Kim H.S. COMP-Ang1 stimulates HIF-1alpha-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 2011, 117:4376-4386.
52. Bedogni B., Welford S.M., Cassarino D.S., Nickoloff B.J., Giaccia A.J., Powell M.B. The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 2005, 8:443-454.